IPO Premiums
IPO calendar
SBListed

Sheel Biotech Limited

Bookbuilding IPO · NSE

Price band
₹59 - ₹63
Lot size
2,000 shares
Issue amount
₹34.02 cr
Total subscription
16.05×
Current price₹61
Listing price ₹91
Watch live price ↗
Opens
30 Sept 2025
Closes
3 Oct 2025
Allotment
6 Oct 2025
Listing
8 Oct 2025

Offer at a glance

Issue overview

Issue size
54,00,000 shares
Face value
₹10 per share
Minimum investment
₹1,18,000
Fresh issue
₹34.02 cr
Offer for sale
₹0 cr
Registrar
Skyline Financial Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,26,000
Issue type
Bookbuilding IPO
Shares before issue
1,49,52,550
Shares after issue
2,03,52,550

Lot sizes

CategoryLotsSharesAmount
RETAIL24,000₹2,52,000
sHNI36,000₹3,78,000
bHNI816,000₹10,08,000

Share reservation

Anchor28.22%
QIB19%
HNI14.33%
RETAIL33.41%
Market Maker5.04%

Subscription & GMP

Subscription by category

Total subscribed16.05×

Reported 3 Oct 2025

QIB19.73×
NIB26.29×
RETAIL9.57×
HNIs(10L+)32.16×
HNIs(2-10L)14.56×

GMP history

07.51526 Sept: ₹029 Sept: ₹030 Sept: ₹01 Oct: ₹23 Oct: ₹64 Oct: ₹65 Oct: ₹26 Oct: ₹87 Oct: ₹153 Nov: ₹1521 Nov: ₹15
26 Sept₹1521 Nov

Day-wise demand

30 Sept0.07×
1 Oct0.37×
2 Oct0.37×
3 Oct16.05×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB018
NIB01,363
RETAIL4514,315
HNIs(10L +)86761
HNIs (2-10L)43602

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs6.46127.54
FIIs037.43
Others090.1
RETAIL11.37108.74
HNIs 2+1.6323.66
HNIs 10+3.25104.55

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
050100150Mar 2022 · Revenue: 71.07Mar 2022 · Profit after tax: 4.51Mar 2022Mar 2023 · Revenue: 80.19Mar 2023 · Profit after tax: 5.08Mar 2023Mar 2024 · Revenue: 92.55Mar 2024 · Profit after tax: 10.51Mar 2024Mar 2025 · Revenue: 102.27Mar 2025 · Profit after tax: 10.63Mar 2025
RevenueProfit after tax

Key performance indicators

MetricMar-25Mar-24Mar-23
EPS7.217.223.5
ROE13.5915.388.23
ROCE000
RONW13.5915.388.23
PRE IPO(PE)8.9600
POST IPO(PE)44.0700

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Sheel Biotech LimitedNANA1056.8413.597.21
Jain Irrigation Systems Limited143.9751.83272.070.50.36
Vrundavan Plantation Limited14.24471044.637.393.3

Company information

Company profile

Sheel Biotech Limited, incorporated in November 1991, specializes in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops using tissue culture and hydroponics, and provides greenhouse manufacturing, farmer services, and training through FPOs. It also offers landscaping services to government and private clients and holds ISO certifications for quality, environment, and safety. Its R&D lab is recognized by India’s Department of Biotechnology and Department of Science and Technology. Sheel Biotech supports organic farming adoption, manages FPOs, implements turnkey horticultural projects with modern technologies, and conducts training programs for farmers and agripreneurs. As of September 30, 2024, it had 160 permanent employees.

Strengths

  • Biotechnology and Greenhouse Expertise: Skilled in tissue culture, organic farming, and modern horticultural technologies.
  • Wide Product and Service Range: Offers planting materials, turnkey greenhouse projects, organic certification, FPO support, and training.
  • Sustainability and Recognition: Follows eco-friendly practices and holds government-recognized R&D and international quality, safety, and environmental certifications.

Risk factors

  • Strict Precision in Tissue Culture: Lapses in sterilization, storage, or temperature control can lead to contamination and significant losses.
  • Dependence on Government Tenders: Revenue from organic farming heavily relies on winning tenders, making it vulnerable to policy or tender changes.
  • Operational Risks in Production: Small errors in tissue culture processes can disrupt the entire production cycle.

Promoters

Dr. Satya Narayan Chandak

Mr. Sanjay Chandak

Mr. Divye Chandak

Mrs. Mini Chadha

M/s Satya Narayan Chandak (HUF)

M/s Sanjay Chandak (HUF)

M/s Sumeet Chandak (HUF)

Registrar & documents

Lead manager

Narnolia Financial Services Limited

Registered office

8 Balaji Estates , 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019

+91 88511 - 8980

[email protected]Company website ↗

Frequently Asked Questions

What is Sheel Biotech IPO GMP today?

As of today, Sheel Biotech IPO Grey Market Premium (GMP) is reported at +₹15 per share. Based on the upper price band of ₹63, the estimated listing price is ₹78 (+23.8% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Sheel Biotech IPO?

The minimum bid lot size for Sheel Biotech IPO is 2,000 shares. At the cut-off price of ₹63 per share, retail investors need a minimum application amount of ₹1,26,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Sheel Biotech IPO allotment status be announced?

The allotment status for Sheel Biotech IPO is scheduled to be finalized on 6 Oct 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Sheel Biotech IPO allotment status online by PAN?

To check Sheel Biotech IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'Sheel Biotech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.